Literature DB >> 10023786

Early childhood neurodevelopment in very low birth weight infants with predischarge apnea.

P Y Cheung1, K J Barrington, N N Finer, C M Robertson.   

Abstract

Apnea commonly occurs in preterm infants and may persist beyond term. We prospectively investigated the relationship between apnea that persisted beyond 35 weeks post-conceptional age and subsequent neurodevelopment in early childhood. Between January, 1990-November, 1993, we performed predischarge respiratory recordings, using 24-hr, 4-channel pneumography, at 35 weeks or more of postconceptional age in 164 infants (birth weight, <1,250 g; gestational age, < or = 32 weeks), who subsequently underwent multidisciplinary neurodevelopmental assessment at 15-64 (median 24) months of adjusted age. The duration of initial artificial ventilation for respiratory distress syndrome and the grade of intraventricular hemorrhage were independent predictors of neurodevelopmental outcome. Mean oximetry desaturation and frequency of predischarge apnea correlated with mental and motor developmental scores. Mean oximetry desaturation during apnea was an independent predictor for motor score in the total population, and for both mental and motor scores in 50 infants with grade 3 or 4 intraventricular hemorrhage, but not in 114 infants without grade 3 or 4 intraventricular hemorrhage. Despite its limited predictability for early childhood neurodevelopment, predischarge respiratory recordings may be useful in predicting subsequent neurodevelopment of high-risk preterm infants, especially those with severe intraventricular hemorrhage.

Entities:  

Mesh:

Year:  1999        PMID: 10023786     DOI: 10.1002/(sici)1099-0496(199901)27:1<14::aid-ppul4>3.0.co;2-0

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  12 in total

1.  Low oxygen saturation target range is associated with increased incidence of intermittent hypoxemia.

Authors:  Juliann M Di Fiore; Michele Walsh; Lisa Wrage; Wade Rich; Neil Finer; Waldemar A Carlo; Richard J Martin
Journal:  J Pediatr       Date:  2012-06-26       Impact factor: 4.406

2.  Longitudinal assessment of hemoglobin oxygen saturation in preterm and term infants in the first six months of life.

Authors:  Carl E Hunt; Michael J Corwin; Debra E Weese-Mayer; Sally L Davidson Ward; Rangasamy Ramanathan; George Lister; Larry R Tinsley; Tim Heeren; Denis Rybin
Journal:  J Pediatr       Date:  2011-04-09       Impact factor: 4.406

Review 3.  Prophylactic doxapram for the prevention of morbidity and mortality in preterm infants undergoing endotracheal extubation.

Authors:  D J Henderson-Smart; P G Davis
Journal:  Cochrane Database Syst Rev       Date:  2000

4.  Unbound unconjugated hyperbilirubinemia is associated with central apnea in premature infants.

Authors:  Sanjiv B Amin; Hongyue Wang
Journal:  J Pediatr       Date:  2015-01-14       Impact factor: 4.406

Review 5.  Risks and benefits of therapies for apnoea in premature infants.

Authors:  J M Hascoet; I Hamon; M J Boutroy
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 6.  Treatment of apnea of prematurity.

Authors:  Varsha Bhatt-Mehta; Robert E Schumacher
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

7.  Monitoring apnea of prematurity: validity of nursing documentation and bedside cardiorespiratory monitor.

Authors:  Sanjiv B Amin; Erica Burnell
Journal:  Am J Perinatol       Date:  2012-12-19       Impact factor: 1.862

8.  Hyperbilirubinemia diminishes respiratory drive in a rat pup model.

Authors:  Oded Mesner; Martha J Miller; Sabine C Iben; K C Prabha; Catherine A Mayer; Musa A Haxhiu; Richard J Martin
Journal:  Pediatr Res       Date:  2008-09       Impact factor: 3.756

9.  Preterm infants' behavioural indicators of oxygen decline during bottle feeding.

Authors:  Suzanne M Thoyre; John R Carlson
Journal:  J Adv Nurs       Date:  2003-09       Impact factor: 3.187

Review 10.  Carnitine supplementation for preterm infants with recurrent apnea.

Authors:  M Kumar; N S Kabra; B Paes
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.